Jeremy Halpern

    Recent posts

  • Angels in Life Science America

    What happens when the FDA approval process slows down and imposes higher hurdles, when cost-reduction becomes central to the healthcare provider business model, when clinical trials and commercialization costs for medical... Read more »

Page 1 of 1